Medprin Regenerative Medical Technologies Co (SZSE:301033) Debt-to-Asset : 0.07 (As of Mar. 2024)

Medprin Regenerative Medical Technologies Co Debt-to-Asset Chart

Medprin Regenerative Medical Technologies Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.08	0.08	0.07	0.07	0.07

Competitive Comparison of Medprin Regenerative Medical Technologies Co's Debt-to-Asset

For the Medical Devices subindustry, Medprin Regenerative Medical Technologies Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medprin Regenerative Medical Technologies Co's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medprin Regenerative Medical Technologies Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Medprin Regenerative Medical Technologies Co's Debt-to-Asset falls into.

Medprin Regenerative Medical Technologies Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Medprin Regenerative Medical Technologies Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Medprin Regenerative Medical Technologies Co's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medprin Regenerative Medical Technologies Co  (SZSE:301033) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Medprin Regenerative Medical Technologies Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Medprin Regenerative Medical Technologies Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Medprin Regenerative Medical Technologies Co (SZSE:301033) Business Description